From The Hindu BusinessLine
Center-Right Owned by The Hindu Group (Kasturi & Sons)Emcure Pharma shares jump 9% after Q2 net profit rise
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
right · 2 outlets
The pharma player's consolidated bottom-line rose 81.1% to Rs 335 crore in the September quarter from Rs 185 crore in the year-ago period.
— NDTV
RSS excerpt
Emcure reported a 29.31% increase in consolidated net profit to ₹325.06 crore during the September quarter
